Visionary Venture Fund
Venture Capital
Active
Newport Beach, United States
21
22M
16
2.62
4
0.24
3
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The leading representative office of defined VC is situated in the Aliso Viejo.
The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 25 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2017. The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2018. This Visionary Venture Fund works on 11 percentage points less the average amount of lead investments comparing to the other organizations.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Visionary Venture Fund, startups are often financed by Tigris Ventures, Sequoia Capital Israel, Flying L Partners. The meaningful sponsors for the fund in investment in the same round are Flying L Partners, Bluestem Capital, Vivo Capital. In the next rounds fund is usually obtained by Petrichor Healthcare Capital Management, Global Health Investment Fund (GHIF), Flying L Partners.
Among the most popular portfolio startups of the fund, we may highlight CorneaGen, Mynosys, Iantech. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Chemical Engineering, Pharmaceutical.
The current fund was established by Ehsan Sadri.
Investor highlights
- Industry focus
- Stage focus
- Check size
- 5M — 15M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 114000000
- Fund raised date
- 2021-03-23
Analytics
- Total investments
- 21
- Lead investments
- 4
- Exits
- 3
- Rounds per year
- 2.62
- Follow on index
- 0.24
- Investments by industry
- Health Care (15)
- Medical Device (10)
- Medical (9)
- Pharmaceutical (8)
- Biotechnology (7) Show 12 more
- Investments by region
-
- United States (17)
- Israel (2)
- United Kingdom (2)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.76
- Avg. company exit year
- 4
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Epost | 05 Apr 2018 | Logistics, E-Commerce, Information Technology, Insurance, IT Infrastructure | Seed | 121K | Malaysia, Kuala Lumpur |
| Eastern Gear | 01 Sep 2021 | Manufacturing, Product Design, Industrial | Seed | Gangwon-do, South Korea, South Korea | |
| NOCA Beverages | 15 Nov 2019 | Consumer Goods, Food and Beverage, Health Care | Seed | United States, Massachusetts, Boston | |
| Pelage Pharma | 27 Feb 2024 | Health Care, Medical, Pharmaceutical | Early Stage Venture | 16M | United States, California, Los Angeles |
| Surface Pharmaceuticals | 11 Jul 2018 | Health Care, Pharmaceutical, Biopharma | Early Stage Venture | 21M | United States, California |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.